ASSET PURCHASE AGREEMENTAsset Purchase Agreement • February 19th, 2019 • Bioblast Pharma Ltd. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 19th, 2019 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of February 15, 2019, by and among Seelos Therapeutics, Inc., a Nevada corporation (“Buyer”), and Bioblast Pharma, Ltd., an Israeli corporation (“Seller”). Buyer and Seller may be referred to herein collectively as the “Parties” and individually as a “Party.”